Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label Study to Evaluate the Safety of NP101, a Sumatriptan Iontophoretic Transdermal Patch, in the Treatment of Acute Migraine Over 12 Months

NCT00806546 is registered in ClinicalTrials.gov with NuPathe Inc. as lead sponsor.

NCT NCT00806546
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00806546 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label Study to Evaluate the Safety of NP101, a Sumatriptan Iontophoretic Transdermal Patch, in the Treatment of Acute Migraine Over 12 Months
Lead sponsor
NuPathe Inc.
Phase
Phase 3
Overall status
Completed
Start date
February 28, 2009
Completion date
May 31, 2011
Enrollment
514 (actual)
Sites
31

Conditions

As the registry lists them; a condition with its own page is linked.

migraine disorders